| Identification | Back Directory | [Name]
PROTAC SMARCA2 degrader-2 | [CAS]
2892523-74-7 | [Synonyms]
PROTAC SMARCA2 degrader-2
(2S,4R)-4-hydroxy-1-[(2R)-2-{3-[2-(4-{[3'-(2-hydroxyphenyl)-7',8'-dihydro-5'H-spiro[piperidine-4,6'-pyridazino[3,4-b]pyrazin]-1-yl]methyl}piperidin-1-yl)ethoxy]-1,2-oxazol-5-yl}-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide |
| Hazard Information | Back Directory | [Uses]
PROTAC SMARCA2 degrader-2 is a potent and selective SMARCA2/4 PROTAC degrader with an IC50 of <0.1 μΜ in HeLa HiBiT assay. PROTAC SMARCA2 degrader-2 is extracted from patent WO2023287787A1 and has the potential for SMARCA4-related or deficient cancer research[1]. | [References]
[1] Liang Lu, et al. Brm targeting compounds and associated methods of use. Patent WO2023287787A1. |
|
|